Bausch Health Companies Inc (BHC): Bausch Health in-licenses dry eye candid...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Bausch Health Companies Inc (BHC)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	224
Posts	31832
Boards Moderated	4
Alias Born	10/10/2005

Re: Monika75 post# 4779

Friday, 12/20/2019 9:13:00 AM

Friday, December 20, 2019 9:13:00 AM

Bausch Health in-licenses dry eye candidate from Novaliq GmgH

Dec. 20, 2019 8:47 AM ET|About: Bausch Health Companie... (BHC)|

By: Douglas W. House, SA News Editor

Bausch Health Companies (NYSE:BHC) unit Bausch + Lomb inks an agreement with Heidelberg, Germany-based Novaliq GmbH for exclusive U.S. and Canadian rights to NOV03 (perfluorohexyloctane) for the potential treatment of dry eye disease associated with Meibomian gland dysfunction (gland that secretes oils onto the surface of the eye).

Under the terms of the deal, Novaliq will receive upfront and milestone payments and royalties on net sales. Specific financial terms are not disclosed. BHC has the right to pursue additional ophthalmic indications for NOV03, alone and in combination (Novaliq will be eligible for additional payments and royalties for the combo products).

A Phase 2 trial was successful, achieving the primary endpoint of a statistically significant improvement of total corneal fluorescein staining at week 8 versus placebo.

A Phase 3 study is in process. BHC plans to start another Phase 3 in 2020.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BHC News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:24:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:19:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:16:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 03:36:17 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 10:04:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:04:41 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:30:26 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 02:00:18 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 10:18:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:19:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:18:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:16:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:15:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:35:35 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/05/2023 04:12:39 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2023 09:50:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2023 10:06:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2023 04:09:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:58:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 11:05:39 AM
Bausch Health Gets FDA Approval for Acne Treatment Cabtreo • Dow Jones News • 10/20/2023 10:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:29:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:28:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:27:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:25:30 PM

More BHC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow